Johnson & Johnson (JNJ) vs NVIDIA Corporation (NVDA)

Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.

NVIDIA is a leading designer of graphics processing units (GPUs). Historically, GPUs were used to improve performance and user experience across computing platforms, especially in PC gaming. Over time, GPUs have become essential semiconductors for artificial intelligence, powering large language models and other advanced AI workloads. In addition to AI-focused GPUs, NVIDIA provides its CUDA software platform, which supports AI model development and training. The company is also expanding its data center networking solutions, helping connect GPUs to manage increasingly complex workloads.